Latest Insider Transactions at Crinetics Pharmaceuticals, Inc. (CRNX)
This section provides a real-time view of insider transactions for Crinetics Pharmaceuticals, Inc. (CRNX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Crinetics Pharmaceuticals, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Crinetics Pharmaceuticals, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 31
2020
|
Vivo Capital Viii, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
5,400
-0.75%
|
$113,400
$21.7 P/Share
|
|
Jan 30
2020
|
Vivo Capital Viii, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
7,600
-1.03%
|
$167,200
$22.1 P/Share
|
|
Jan 29
2020
|
Vivo Capital Viii, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
13,920
-1.79%
|
$306,240
$22.2 P/Share
|
|
Dec 16
2019
|
Matthew K Fust |
SELL
Open market or private sale
|
Direct |
3,500
-21.83%
|
$77,000
$22.5 P/Share
|
|
Dec 16
2019
|
Matthew K Fust |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+17.92%
|
$3,500
$1.91 P/Share
|
|
Aug 05
2019
|
Richard Scott Struthers President & CEO |
BUY
Exercise of conversion of derivative security
|
Indirect |
10,000
+0.81%
|
$10,000
$1.91 P/Share
|
|
Jun 21
2019
|
5 Am Ventures Iv, L.P. |
SELL
Open market or private sale
|
Indirect |
250,000
-9.57%
|
$5,500,000
$22.2 P/Share
|
|
May 08
2019
|
Richard Scott Struthers President & CEO |
BUY
Bona fide gift
|
Indirect |
1,215,805
+50.0%
|
-
|
|
May 08
2019
|
Richard Scott Struthers President & CEO |
SELL
Bona fide gift
|
Direct |
1,215,805
-100.0%
|
-
|
|
Mar 20
2019
|
Vivo Capital Viii, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
417,000
-15.96%
|
$9,174,000
$22.25 P/Share
|
|
Mar 18
2019
|
5 Am Ventures Iv, L.P. |
SELL
Open market or private sale
|
Indirect |
154,839
-5.6%
|
$3,716,136
$24.25 P/Share
|
|
Feb 20
2019
|
5 Am Ventures Iv, L.P. |
BUY
Other acquisition or disposition
|
Indirect |
9,869
+41.52%
|
-
|
|
Feb 20
2019
|
5 Am Ventures Iv, L.P. |
SELL
Other acquisition or disposition
|
Indirect |
474,700
-43.01%
|
-
|
|
Feb 04
2019
|
Versant Venture Capital V, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
517,739
-43.33%
|
-
|
|
Feb 04
2019
|
Versant Venture Capital V, L.P. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
10,151
+50.0%
|
-
|
|
Jan 22
2019
|
5 Am Ventures Iv, L.P. |
SELL
Open market or private sale
|
Indirect |
262,153
-7.49%
|
$5,505,213
$21.88 P/Share
|
|
Jul 20
2018
|
Alan Seth Krasner Chief Medical Officer |
BUY
Open market or private purchase
|
Direct |
2,000
+50.0%
|
$34,000
$17.0 P/Share
|
|
Jul 20
2018
|
Versant Venture Capital V, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,384,276
+31.1%
|
-
|
|
Jul 20
2018
|
Vivo Capital Viii, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
353,180
+21.9%
|
$6,004,060
$17.93 P/Share
|
|
Jul 20
2018
|
Vivo Capital Viii, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,384,278
+31.1%
|
-
|
|
Jul 20
2018
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
400,000
+14.92%
|
$6,800,000
$17.0 P/Share
|
|
Jul 20
2018
|
Perceptive Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
1,880,305
+50.0%
|
-
|
|
Jul 20
2018
|
5 Am Ventures Iv, L.P. |
BUY
Open market or private purchase
|
Indirect |
115,000
+3.18%
|
$1,955,000
$17.0 P/Share
|
|
Jul 20
2018
|
5 Am Ventures Iv, L.P. |
BUY
Conversion of derivative security
|
Indirect |
3,384,278
+31.1%
|
-
|